Skip to content
healthcare.dev

Plerixafor

NDC 25021-416, Plerixafor, injection, solution, from Sagent Pharmaceuticals.

Product NDC
25021-416
Status
Listed
Labeler
Sagent Pharmaceuticals
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206644
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/25021-416 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PLERIXAFOR20 mg/mL

Pharmacologic classes

Hematopoietic Stem Cell Mobilizer [EPC]; Increased Hematopoietic Stem Cell Mobilization [PE]

Package NDCNDC-11Package
25021-416-01250210416011 VIAL in 1 CARTON (25021-416-01) / 1.2 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/711b7bf7-4385-4365-b12a-ede6c3f1ed45
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=25021-416

Use it

Look up 25021-416 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/25021-416 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 25021-416. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.